EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from June 1, 2026 to June 5, 2026 (each inclusive), 441,000 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
1 June 2026	72,000	36.4874	2,627,092.80	XETR
2 June 2026	97,000	36.0553	3,497,364.10	XETR
3 June 2026	110,000	35.8359	3,941,949.00	XETR
4 June 2026	80,000	37.2437	2,979,496.00	XETR
5 June 2026	82,000	38.1152	3,125,446.40	XETR

A total of 596,000 shares has been acquired within the framework of the first tranche of the share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.